Filing Details
- Accession Number:
- 0000950170-24-043690
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-11 16:05:09
- Reporting Period:
- 2024-04-10
- Accepted Time:
- 2024-04-11 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488039 | Atossa Therapeutics Inc. | ATOS | Pharmaceutical Preparations (2834) | 264753208 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1981595 | Jonathan Finn | C/O 107 Spring Street Seattle WA 98104 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-10 | 25,000 | $1.77 | 25,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.74 to $1.78. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, The Reporting Person will provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
